Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Axxess Pharma, specialising in the marketing and distribution of both prescription and non-prescription medical products, is planning to enter into an exclusive license agreement to manufacture and distribute an FDA approved high potency cough and cold capsule.
Subscribe to our email newsletter
Axxess Pharma is expecting to sign the exclusive license agreement within next 2 weeks.
The capsule is currently being sold by physicians, pharmacists and specialists in the US, and is expected to be made available in the name of Axxess Pharma in Canada and Middle East following Health Canada approval.
Gerald Sequeira, president and CEO of Axxess Pharma, said: “Our latest prescription cough and cold capsule is anticipated to generate strong global sales for our company. Customers and patients will no longer need to carry bottles of cough and cold medicine.
“The capsule is easy to carry; currently FDA approved and is soon to be approved by Health Canada. We are now in discussion to expand the FDA approved prescription capsule into Africa.”